iShares MSCI ACWI ETF vs Becton Dickinson and Co — how do they compare? iShares MSCI ACWI ETF trades at $162, while Becton Dickinson and Co trades at $180.75 (market cap $49.41B). The key difference: Becton Dickinson and Co pays a 2.32% dividend while iShares MSCI ACWI ETF pays none, and iShares MSCI ACWI ETF is trading nearer its 52-week high, Becton Dickinson and Co nearer its low. Which is the better fit depends on your goals.
| ACWI | BDX | |
|---|---|---|
52-Week High | $161.44 | $185.39 |
52-Week Low | $132.04 | $138.62 |
Market Cap | — | $49.41B |
Sector | — | Health |
Enterprise Value | — | $65.51B |
Dividend Yield | — | 2.32% |
Trailing returns across standard periods
Latest headlines on both assets
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The index is a free float-adjusted market capitalization index designed to measure the combined equity market performance of developed and emerging markets countries.
Read more on ACWI →Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →